Formulations built around real procurement needs.

Diabetic Range

Bilayered TabletSingle ingredient

"Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg Tablets (uncoatedbilayered)"

"Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg Tablets (uncoatedbilayered)" is a bilayered tablet formulated with "Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg (uncoatedbilayered)". Th

Available strengths

"Glimepiride Img. Pioglitazone Hcl 1Smg + Metformin Hcl (Extended Released) 500mg (uncoatedbilayered)"

Cardiac Range

TabletSingle ingredient

Amlodipine 5mg + Atenolol 50mg Tab (Uncoated)

Amlodipine 5mg + Atenolol 50mg Tab (Uncoated) is a tablet formulated with Amlodipine 5mg + Atenolol 50mg ( ). The listed active ingredient profile is Amlodipine; Atenolol, placing the product in the antihypertensive / cardiovascular category. The formulat

Available strengths

Amlodipine 5mg + Atenolol 50mg ( )

Cardiac Range

TabletSingle ingredient

Amlodipine 5mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg Tab (Film coated)

Amlodipine 5mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg Tab (Film coated) is a tablet formulated with Amlodipine 5mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg ( ). The listed active ingredient profile is Amlodipine; Telmisartan; Hydrochloroth

Available strengths

Amlodipine 5mg + Telmisartan 40mg + Hydrochlorothiazide 12.5mg ( )

Cardiac Range

TabletSingle ingredient

Amlodipine 5mg Tab Uncoated

Amlodipine 5mg Tab Uncoated is a tablet formulated with Amlodipine 5mg. The listed active ingredient profile is Amlodipine, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more cardiovascular medicine

Available strengths

Amlodipine 5mg

Cardiac Range

TabletSingle ingredient

Atorvastatin 10mg + Fenofibrate 160mg Tab. (Film coated)

Atorvastatin 10mg + Fenofibrate 160mg Tab. (Film coated) is a tablet formulated with Atorvastatin 10mg + Fenofibrate 160mg . ( ). The listed active ingredient profile is Atorvastatin; Fenofibrate, placing the product in the lipid-lowering therapy category

Available strengths

Atorvastatin 10mg + Fenofibrate 160mg . ( )

Cardiac Range

TabletSingle ingredient

Atorvastatin 10mg Tab. (Film Coated)

Atorvastatin 10mg Tab. (Film Coated) is a tablet formulated with Atorvastatin 10mg . ( ). The listed active ingredient profile is Atorvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s)

Available strengths

Atorvastatin 10mg . ( )Atorvastatin 40mg . ( )

Cardiac Range

TabletSingle ingredient

Atorvastatin 20mg Tab. (Film)

Atorvastatin 20mg Tab. (Film) is a tablet formulated with Atorvastatin 20mg . (Film). The listed active ingredient profile is Atorvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s) use

Available strengths

Atorvastatin 20mg . (Film)

Cardiac Range

TabletSingle ingredient

Cilnidipine Tablets IP 5mg (Film coated)

Cilnidipine Tablets IP 5mg (Film coated) is a tablet formulated with Cilnidipine IP 5mg ( ). The listed active ingredient profile is Cilnidipine, placing the product in the antihypertensive / cardiovascular category. The formulation contains one or more c

Available strengths

Cilnidipine IP 5mg ( )Cilnidipine IP 10mg ( )Cilnidipine IP 20mg ( )

Diabetic Range

TabletSingle ingredient

Dapagliflozin 10 mg + Metformin IP S00 mg (Film coated Tablet)

Dapagliflozin 10 mg + Metformin IP S00 mg (Film coated Tablet) is a tablet formulated with Dapagliflozin 10 mg + Metformin IP S00 mg ( ). The listed active ingredient profile is Dapagliflozin; Metformin S00 mg, placing the product in the oral antidiabetic

Available strengths

Dapagliflozin 10 mg + Metformin IP S00 mg ( )

Diabetic Range

TabletSingle ingredient

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet)

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg (Film coated bilayred Tablet) is a tablet formulated with Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg ( ). The listed active ingredient profile is Dapagliflozin; Metformin Hydrochloride, plac

Available strengths

Dapagliflozin 5mg + Metformin Hydrochloride IP 500 mg ( )Dapagliflozin 5 mg + Metformin Hydrochloride IP 1000 mg ( )

Diabetic Range

TabletSingle ingredient

Dapagliflozin 5mg Tablets (Film coated)

Dapagliflozin 5mg Tablets (Film coated) is a tablet formulated with Dapagliflozin 5mg ( ). The listed active ingredient profile is Dapagliflozin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowe

Available strengths

Dapagliflozin 5mg ( )Dapagliflozin 10mg ( )

Diabetic Range

TabletSingle ingredient

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg is a tablet formulated with Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg. The listed active ingr

Available strengths

Dapagliflozin propanediol monohydrate Eq to dapagliflozine 10mg + Metformin hydrochloride (ER) 1000mg

Diabetic Range

TabletSingle ingredient

Gliclazide 80mg + Metformin hydrochloride 500mg Tablets (Uncoated Blayered)

Gliclazide 80mg + Metformin hydrochloride 500mg Tablets (Uncoated Blayered) is a tablet formulated with Gliclazide 80mg + Metformin hydrochloride 500mg ( Blayered). The listed active ingredient profile is Gliclazide; Metformin hydrochloride, placing the p

Available strengths

Gliclazide 80mg + Metformin hydrochloride 500mg ( Blayered)

Diabetic Range

TabletSingle ingredient

Gliclozide 80mg + Metformin hydrochloride 800mg Tablets (enterlc coated)

Gliclozide 80mg + Metformin hydrochloride 800mg Tablets (enterlc coated) is a tablet formulated with Gliclozide 80mg + Metformin hydrochloride 800mg (enterlc coated). The listed active ingredient profile is Gliclozide; Metformin hydrochloride, placing the

Available strengths

Gliclozide 80mg + Metformin hydrochloride 800mg (enterlc coated)

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride 2mg + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered)

Glimepiride 2mg + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg + Metformin HCI (SR) 500mg . ( ). The listed active ingredient profile is Glimepiride; Metformin HCI, placing the product in the ora

Available strengths

Glimepiride 2mg + Metformin HCI (SR) 500mg . ( )Glimepiride 2mg + Metformin HCI (SR) 1000 mg . ( )

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered)

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg IP ( ). The listed active ingredient profile is Glimepiride; Metf

Available strengths

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 1000mg IP ( )

Diabetic Range

TabletSingle ingredient

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered)

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered) is a tablet formulated with Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered). The listed active ingredient profile is Glimepiride; Metformin

Available strengths

Glimepiride 2mg + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered)

Diabetic Range

TabletSingle ingredient

Glimepiride 2mg Tab. (Uncoated)

Glimepiride 2mg Tab. (Uncoated) is a tablet formulated with Glimepiride 2mg . ( ). The listed active ingredient profile is Glimepiride, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medic

Available strengths

Glimepiride 2mg . ( )

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg Tablets (Uncoated Bilayered)

Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg ( ). The listed active ingredient pr

Available strengths

Glimepiride 2mg, Metformin Hcl (Sustained Released) 500mg + Voglibose 0.2mg ( )

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg Tablets (uncoted bilayered)

Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg Tablets (uncoted bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg (uncoted ). The listed acti

Available strengths

Glimepiride 2mg, Pioglitazone Hcl 15mg + Metformin Hcl (Extended Released)1000mg (uncoted )

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg Tablets (uncoted bilayered)

Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg Tablets (uncoted bilayered) is a bilayered tablet formulated with Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg (uncoted ). The listed acti

Available strengths

Glimepiride 2mg, Ploglitozone Hcl 15mg + Metformin Hcl (Extended Reledsed) 500mg (uncoted )

Diabetic Range

TabletSingle ingredient

Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg

Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg is a tablet formulated with Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg. The listed active ingredient profile is Glimepiride; Metformin Hydrochloride, placing the product in the oral antidiabet

Available strengths

Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride Img + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered)

Glimepiride Img + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride Img + Metformin HCI (SR) 500mg . ( ). The listed active ingredient profile is Glimepiride Img; Metformin HCI, placing the product in the

Available strengths

Glimepiride Img + Metformin HCI (SR) 500mg . ( )Glimepiride Img + Metformin HCI(SR) 1000 mg . ( )

Diabetic Range

Bilayered TabletSingle ingredient

Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered)

Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg IP ( ). The listed active ingredient profile is Glimepiride Img;

Available strengths

Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg IP ( )

Diabetic Range

TabletSingle ingredient

Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered)

Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered) is a tablet formulated with Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered). The listed active ingredient profile is Glimepiride Img; Metfo

Available strengths

Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered)